Red Light on the Horizon: Ophthalmologists’ Perspectives on RLRL
Available from: 2/12/2025 (AEDT)
Where to publish: www.mieducation.com
Provider: Mivision
Contact: Nikki Byrne, [E] nikki@mivision.com.au, [P] 02 8336 8616
Activity Outline
In this article, Eyerising International’s Dr Yuri Aung hears from four leading ophthalmologists from around the world – Dr Loren Rose (Australia), Professor Jason Yam (Hong Kong), Mr John Bolger (United Kingdom), and Professor Junwen Zeng (China) – as they share their expert perspectives on repeated low-level red-light therapy (RLRL) for myopia with case studies from a range of difficult-to-treat patients.
Learning Objectives
- Understand the latest evidence behind repeated low-level red-light (RLRL) therapy for myopia control
- Be able to identify patients that would be appropriate to start RLRL, and
- Know how to monitor and follow up patients on RLRL
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| Red Light on the Horizon: Ophthalmologists’ Perspectives on RLRL |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.5 |